CERVICAL CANCER BY FIGO STAGE 2018
Clinical trials for CERVICAL CANCER BY FIGO STAGE 2018 explained in plain language.
Never miss a new study
Get alerted when new CERVICAL CANCER BY FIGO STAGE 2018 trials appear
Sign up with your email to follow new studies for CERVICAL CANCER BY FIGO STAGE 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop advanced cervical cancer from returning
Disease control Not yet recruitingThis study tests whether adding two drugs, pembrolizumab and lenvatinib, to standard chemoradiation can keep high-risk cervical cancer from coming back. About 87 adults with advanced cervical cancer will receive the drugs alongside radiation and brachytherapy. The main goal is to…
Matched conditions: CERVICAL CANCER BY FIGO STAGE 2018
Phase: PHASE2 • Sponsor: Prof. Dr. Remi A. Nout • Aim: Disease control
Last updated May 17, 2026 11:38 UTC
-
Spare the bone, save the blood: new radiation approach aims to prevent dangerous side effects in cervical cancer
Symptom relief Not yet recruitingThis study tests whether carefully avoiding the pelvic bones during radiation therapy can reduce severe blood-related side effects (like low red blood cells, white blood cells, and platelets) in women with advanced cervical cancer. About 72 women will receive standard chemoradiat…
Matched conditions: CERVICAL CANCER BY FIGO STAGE 2018
Phase: NA • Sponsor: Institut Paoli-Calmettes • Aim: Symptom relief
Last updated May 17, 2026 11:37 UTC